Evaluating a Team-Based Medication Review to Improve Drug Use in Older Adults at an Intermediate Care Hospital

What this Trial Is About

Researchers are evaluating whether a patient-centered medication review by a multidisciplinary team can improve treatment adequacy for older adults admitted to an intermediate care hospital. This study focuses on reducing the average number of medications taken per patient by comparing this approach to the usual care, which involves a medication review by a clinical pharmacist alone. Participants will be randomly assigned to either the intervention group receiving a comprehensive medication review by a team including geriatricians, pharmacists, and nurses, or the control group receiving standard care led by a clinical pharmacist. The intervention is based on a detailed evaluation of personal, clinical, diagnostic, and drug-related factors tailored to the patient. During the study, participants will undergo a thorough assessment, complete health status and attitude questionnaires, and have any medication-related adverse events recorded at discharge. Follow-up contact occurs three months after discharge to check for hospital readmission or death. The primary outcome is the average number of drugs taken at baseline and about 30 days after discharge, with the study expected to continue until June 2026.

Applying a Multidisciplinary Intervention for Drug Adequacy in an Intermediate Care Hospital (AMIDA-ICH)